ECG Monitoring During Macrolide Therapy: Who Needs It?
Apr 22 2026
Multiple System Atrophy (MSA-P) is a rare, aggressive neurological disorder with parkinsonian symptoms and severe autonomic failure. Unlike Parkinson’s, it progresses rapidly, responds poorly to treatment, and has a median survival of only 6-10 years.
Apr 22 2026
Sep 25 2025
Apr 5 2026
Jul 3 2026
Nov 18 2025